ALIPAY+
Whale Cloud , a leading technology company providing software solutions and services for telecommunications and multiple other industries, today reached a partnership with Toka Fintech , a Mexican-leading financial group, to help it develop its own digital payment app with Alipay+ Digital Wallet Solution, providing Mexicans with better access to inclusive financial services.
Toka Fintech is a company belonging to Grupo Toka, which is one of the most important groups in the prepaid card market and has more than 4.5 million customers in Mexico. Grupo Toka is increasingly embracing digital payment services because of the fast adoption of smartphones in the country and the COVID-19 pandemic.
In this partnership, with proven payment technology, project delivery and operation experience from Whale Cloud and Ant Group in global markets, Toka Fintech will further embark on its digital payment journey and bring the inclusive, digitalized and personalized services to more businesses and customers in Mexico.
Whale Cloud and Ant Group will help Toka Fintech develop an all-in-one digital payment app tailored for Latin America market, providing comprehensive payment services powered by innovative technologies including financial-grade cloud native computing and AI-driven risk management.
“As a company that aims to continuously create value for customers, Toka Fintech is taking the lead in encouraging the use of innovative technologies in the delivery of financial services. The partnership with Ant Group and Whale Cloud is a milestone for us to advance financial inclusion,” said Hugo Villanueva, CEO and Owner of Toka Fintech.
“We’re excited to serve the digital payment journey of Toka Fintech,” said Cheng Guoming, General Manager of Alipay+ Global Partnership, Ant Group. “Together with Whale Cloud, we are willing to share our technical know-how and experiences to accelerate customers’ digital transformation and help underbanked communities across the world enjoy more inclusive services.”
“Toka Fintech will be the first in Latin America to adopt Alipay+ Digital Wallet Solution. Whale Cloud is so happy to turn Toka’s strategy into actions to reinforce its market position in advancing inclusive digital services”, said Ben Zhou, CEO International, Whale Cloud.
Alipay+ Digital Wallet Solution provides a full-suite of payment technologies and products to help customers develop their own e-wallet apps more efficiently, enable their users to top up, transfer, withdraw money and enjoy financial services directly from mobile devices, while allow merchants to accept these users' online and offline payments, and manage their own loyalty and promotion campaigns.
Whale Cloud and Ant Group have formed a strategic partnership since 2020 to provide customers across industries with financial technology consulting, solution designing and delivery, and operation services.
About Grupo Toka and Toka Fintech
Toka Internacional, S.A.P.I. de C.V. “Toka” is a Mexican Company active in the issue of payment solutions, through electronic wallets in order to provide food, fuel, restaurant, travel allowance, etc. voucher services. The company started providing call center services to financial institutions and in 2012 they launched their first pre-payment card, business that has grown rapidly and become one of the top 5 electronic wallet issuer companies in Mexico.
In 2019 Toka created “Toka Fintech” as a strategy for continuous growth and taking advantage of the opportunity created by the new Fintech law in Mexico to commercialize its products to a B2C open market.
About Whale Cloud
Whale Cloud Technology Co., Ltd ("Whale Cloud") is a leading technology company specializing in telecom software development and delivery, cloud computing, big data analytics, AI-enabled service operations, IoT, Fintech solutions and other professional services including planning and consulting. Founded in 2003, the company provides services to various market segments including telecom operators, governments, and enterprises around the world. Whale Cloud’s business scope extends from telecom markets to vertical industries. It has built its core competitiveness in communications software, operation services, cloud computing, big data analytics, AI, and Internet architecture.
About Alipay+
Alipay+ provides global cross-border mobile payments and marketing solutions that enable global e-wallets and merchant partners, especially small and medium-sized businesses, to better serve their users and customers.
Alipay+ is introduced by Ant Group, the owner and operator of Alipay. One of the world’s leading digital payment platforms, Alipay serves hundreds of millions of users by connecting them with merchants and partner financial institutions that offer inclusive financial services and digital daily life services.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211109006725/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Welcomes Increased Equity Investment From L’Oréal8.12.2025 07:05:00 CET | Press release
L’Oréal to acquire an additional 10% stake in Galderma recognizing its scientific leadership in dermatology and long-term growth potential Ad hoc announcement pursuant to Art. 53 LR Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that L’Oréal Groupe intends to increase its equity investment in the company, acquiring an additional 10% stake from Sunshine SwissCo GmbH (a consortium led by EQT, Abu Dhabi Investment Authority (ADIA), and Auba Investment Pte. Ltd., acting as sellers). Following the transaction, which is subject to customary approvals, L’Oréal’s total shareholding in Galderma will rise to 20%, building on its initial investment made in August 2024. The transaction is expected to close in Q1 2026. In connection with this increased investment, Galderma will consider nominating two non-independent board candidates from L’Oréal, replacing the board members representing the consortium led by EQT, at the 2026 Annual General Meeting. Additio
Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 04:37:00 CET | Press release
The Challenge: Deepfakes undermine both the accuracy and fairness of AI face detection due to variations in human features.The Technology: Ant International’s AI model uses a novel ‘Mixture of Experts’-based Adversarial Debiasing approach to achieve superior fairness and accuracy across diverse demographics.The Impact: This advancement strengthens payment security, offering robust protection against deepfake fraud and enhancing eKYC compliance globally. Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the Nati
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release
Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi
Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom